Automated proton treatment planning with robust optimization using constrained hierarchical optimization Journal Article


Authors: Taasti, V. T.; Hong, L.; Deasy, J. O.; Zarepisheh, M.
Article Title: Automated proton treatment planning with robust optimization using constrained hierarchical optimization
Abstract: Purpose: We present a method for fully automated generation of high quality robust proton treatment plans using hierarchical optimization. To fill the gap between the two common extreme robust optimization approaches, that is, stochastic and worst-case, a robust optimization approach based on the p-norm function is used whereby a single parameter, (Formula presented.) , can be used to control the level of robustness in an intuitive way. Methods: A fully automated approach to treatment planning using Expedited Constrained Hierarchical Optimization (ECHO) is implemented in our clinic for photon treatments. ECHO strictly enforces critical (inviolable) clinical criteria as hard constraints and improves the desirable clinical criteria sequentially, as much as is feasible. We extend our in-house developed ECHO codes for proton therapy and integrate it with a new approach for robust optimization. Multiple scenarios accounting for both setup and range uncertainties are included (13scenarios), and the maximum/mean/dose-volume constraints on organs-at-risk (OARs) and target are fulfilled in all scenarios. We combine the objective functions of the individual scenarios using the p-norm function. The p-norm with a parameter (Formula presented.) or (Formula presented.) result in the stochastic or the worst-case approach, respectively; an intermediate robustness level is obtained by employing (Formula presented.) -values in-between. While the worst-case approach only focuses on the worst-case scenario(s), the p-norm approach with a large p value ((Formula presented.) ) resembles the worst-case approach without completely neglecting other scenarios. The proposed approach is evaluated on three head-and-neck (HN) patients and one water phantom with different parameters, (Formula presented.) . The results are compared against the stochastic approach (p-norm approach with (Formula presented.) ) and the worst-case approach, as well as the nonrobust approach (optimized solely on the nominal scenario). Results: The proposed algorithm successfully generates automated robust proton plans on all cases. As opposed to the nonrobust plans, the robust plans have narrower dose volume histogram (DVH) bands across all 13 scenarios, and meet all hard constraints (i.e., maximum/mean/dose-volume constraints) on OARs and the target for all scenarios. The spread in the objective function values is largest for the stochastic approach ((Formula presented.) ) and decreases with increasing (Formula presented.) toward the worst-case approach. Compared to the worst-case approach, the p-norm approach results in DVH bands for clinical target volume (CTV) which are closer to the prescription dose at a negligible cost in the DVH for the worst scenario, thereby improving the overall plan quality. On average, going from the worst-case approach to the p-norm approach with (Formula presented.) , the median objective function value across all the scenarios is improved by 15% while the objective function value for the worst scenario is only degraded by 3%. Conclusion: An automated treatment planning approach for proton therapy is developed, including robustness, dose-volume constraints, and the ability to control the robustness level using the p-norm parameter (Formula presented.) , to fit the priorities deemed most important. © 2020 American Association of Physicists in Medicine
Keywords: constrained optimization; robust optimization; dose volume constraints; p -norm; proton therapy treatment planning
Journal Title: Medical Physics
Volume: 47
Issue: 7
ISSN: 0094-2405
Publisher: American Association of Physicists in Medicine  
Date Published: 2020-07-01
Start Page: 2779
End Page: 2790
Language: English
DOI: 10.1002/mp.14148
PUBMED: 32196679
PROVIDER: scopus
PMCID: PMC8497180
DOI/URL:
Notes: Article -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Linda Xueqi Hong
    88 Hong
  2. Joseph Owen Deasy
    524 Deasy
  3. Vicki Trier Taasti
    8 Taasti